Clinical and Molecular Hepatology (Apr 2024)
Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer – author’s reply
Abstract
No abstracts available.Keywords